SCHEMBL13768660

SCHEMBL13768660

CCOC(=O)C(F)CCCCCCCCCCNC(=O)NC1(CC2C[C@@H]2C)CC1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13768663 0.95 EPHX2 (0.39) EPHX2
SCHEMBL13772390 0.85 EPHX2 (0.42) EPHX2
SCHEMBL13768502 0.84 EPHX2 (0.41) EPHX2
SCHEMBL13768661 0.83 EPHX2 (0.37) EPHX2
SCHEMBL13768667 0.83 EPHX2 (0.36) EPHX2
SCHEMBL13768665 0.82 EPHX2 (0.35) EPHX2
SCHEMBL13768662 0.81 EPHX2 (0.36) EPHX2
SCHEMBL4010714 0.78 EPHX2 (0.69) EPHX2
SCHEMBL3226878 0.78 EPHX2 (0.69) EPHX2
SCHEMBL4010983 0.78 EPHX2 (0.69) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009086429-A1 SOLUBLE EPOXIDE HYDROLASE INHIBITORS ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed
WO-2009086426-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed